Atara Biotherapeutics, Inc. (ATRA)
NASDAQ·Healthcare·Biotechnology
$10.62
+1.53%
Mkt Cap $40.81M
Analyst Ratings
Buy
2
Hold
2
Sell
1
Price Target (7 analysts)
$9.50
Range $6.00 – $13.00
Implied Upside
-10.5%
Consensus $9.50 vs current $10.62
NASDAQ·Healthcare·Biotechnology
$10.62
+1.53%
Mkt Cap $40.81M
Buy
2
Hold
2
Sell
1
Price Target (7 analysts)
$9.50
Range $6.00 – $13.00
-10.5%
Consensus $9.50 vs current $10.62